ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

POLX Polarean Imaging Plc

1.55
0.025 (1.64%)
21 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Polarean Imaging Plc LSE:POLX London Ordinary Share GB00BF3DT583 ORD GBP0.00037
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.025 1.64% 1.55 1.50 1.60 1.625 1.55 1.60 9,184,566 15:58:24
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 891k -11.89M -0.0098 -1.58 18.41M
Polarean Imaging Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker POLX. The last closing price for Polarean Imaging was 1.53p. Over the last year, Polarean Imaging shares have traded in a share price range of 1.10p to 8.25p.

Polarean Imaging currently has 1,207,032,781 shares in issue. The market capitalisation of Polarean Imaging is £18.41 million. Polarean Imaging has a price to earnings ratio (PE ratio) of -1.58.

Polarean Imaging Share Discussion Threads

Showing 7551 to 7572 of 8000 messages
Chat Pages: Latest  308  307  306  305  304  303  302  301  300  299  298  297  Older
DateSubjectAuthorDiscuss
26/9/2024
18:36
Also AGL fell from a £50m mcap now to like £25mcap. Watch it bounce back up again as always.

POLX meanwhile is at a lowly £18mcap, barelt pricing in the cash and technology and revenues. Not only that the board are giving much more conservative guidance which so far it has delivered on, which is why when the interim results came a few weeks ago the price went UP. Unlike rampy Newland at Angle who consistent over promises and under delivers and thus a dump today.

Not only that but POLX is set to have comparable revenues to ANGLE from a much lower market cap all whilst have more cash in the bank AND technology that is an easier sell to the clinical sites and they are coming in their droves.

From 1.5p I fancy 5-6p EOY for POLX.

m_night10
26/9/2024
18:30
Hard disagree here for multiple reasons.

-They have cash until AT LEAST Q1 2026 and as revenue guidance is increasing, as are orders and costs have been reduced already (read the report), I think it's likely the case runway will extend into Q2/Q3 2026, so nearly 2 years from now.

-Revenues are going to be up to 3,000% in 2024 over 2023 (read the report)

-Cash on hand almost = current mcap

-The tech is FDA approved

-The tech has seen a massive uptick in adoption this year

-They have just hired many big names for the sales team to ramp up sales

-The technology is important and isn't priced in the market cap when factoring the above

-The share price is 1.5p and before all of this it touched 100p

-I see a great recover play from here, either to the gap at 3.4p or higher on fundamentals.

Not advice and DYOR.

m_night10
26/9/2024
18:02
Agree someone is dumping this and it's spending way too much money . The last fund raise should have seen huge cost cutting to slash the losses until revenue grew but they didn't and so it's going to be another raise needed well before they get to break even . Of all the ones that have been hit with huge dillution this is the one I like least as it's simply making losses that are to big given the situation
bones698
26/9/2024
11:01
Strong SELL

It will go down like AGL


If you want a gamble

VAST RESOURCES

riskyinvestor
26/9/2024
09:22
Or after a bid or collaboration announcement !
It won’t be small I’m hearing

washingmachine
26/9/2024
09:17
For me the webinar with questions is the start of a new chapter for polx, proper communication with ALL shareholders ....
slicethepie
26/9/2024
07:45
Doesn't take a rocket scientist to see we are at the start of the up cycle within the trading margin of last few months
moontheloon
26/9/2024
07:41
As usual good luck all holders, the places like British bulls only accentuate movements up and down currently buy after stay short for the dip which kinda self fulfils on low volume. Which is one of reasons we will find it hard to break 1.9 without anymore news
moontheloon
25/9/2024
17:00
If your talking about me Loon then your are incorrect i have many investment in companies that ive never posted on.
Just because i dont post doesn't mean 2 say i dont hold.

john henry
25/9/2024
16:36
When people like you arrive we know there's a trade on... then you'll disappear
moontheloon
25/9/2024
11:47
Tick incoming
moontheloon
25/9/2024
11:05
john henry

STX

Put it on your WATCHLIST

Since FDA approval their turnover is going rapid

riskyinvestor
25/9/2024
10:46
Be 1.6 on the mid very soon.
moontheloon
25/9/2024
10:40
If you did and stay long term fair enough. The long term is very compelling from this price
moontheloon
25/9/2024
10:14
1.6 upwards today. There was no reason for the dip below.maybe global scenario... some get rattled and move to cash. Only good coming from the company.
moontheloon
25/9/2024
10:11
So much for you saying you were a long term holder. You will always be just a trader JH. Repect the company and it's prospects don't be a parasite
moontheloon
25/9/2024
10:05
223,416 lasted 14 minutes LOL
john henry
25/9/2024
09:29
Traders Been waiting. If only I had spare funds was desperate to add at 1.49pAh well as long it's going in the right direction this was stupid level. Absolute no brainer investment level!
moontheloon
25/9/2024
09:18
some decent buying volume added
john henry
25/9/2024
06:24
Should be very beneficial and give even more insight.
moontheloon
25/9/2024
06:23
Polarean Imaging plc("Polarean" or the "Company") Virtual Investor Day Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of lung function, announces it will be hosting a virtual investor day on Wednesday 9 October 2024, at 2.00pm BST / 9.00am EST. The event will be held via a Zoom webinar and will feature presentations on Polarean's lung functional Xenon MRI platform, its clinical use and future utility, as well as the Company's commercial strategy and future plans. The event is open to all. A welcome and introduction will be given by Christopher von Jako, Ph.D., CEO of Polarean Imaging. The afternoon will also feature presentations by: · Dr. Chase Hall, Chief Medical Advisor· Dr. Bastiaan Driehuys, Chief Scientific Officer and founder of Polarean· Alex Dusek, Chief Commercial Officer The presentations will be followed by a Q&A session where attendees can submit questions to the management team. To register for the webinar, please use this link: Webinar Registration - Zoom Enquiries
moontheloon
19/9/2024
12:38
This needs some positive news ,unfortunately it's very slow in coming as usual .
bones698
Chat Pages: Latest  308  307  306  305  304  303  302  301  300  299  298  297  Older